1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Landon, C. Guenneugues, M. Barbault, F. Legrain, M. Menin, L. Schott, V. Vovelle, F. Dimarcq, J.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Protein Sci. PRCIEI 0795 0961-8368 13 703 713 10.1110/ps.03404404 14978308 Lead optimization of antifungal peptides with 3D NMR structures analysis. 2004 10.2210/pdb1p00/pdb pdb_00001p00 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 ETD151 mutant 4852.500 defensin ARD1 N19R 1 man polymer no no DKLIGSCVWGAVNYTSNCRAECKRRGYKGGHCGSFANVNCWCET DKLIGSCVWGAVNYTSNCRAECKRRGYKGGHCGSFANVNCWCET A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Archaeoprepona baker's yeast Saccharomyces sample 191427 Archaeoprepona demophon 4932 Saccharomyces cerevisiae plasmid pEM51 database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2004-03-09 1 1 2008-04-29 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession structure of ARD1 structure of ETD135, mutant of ARD1 SEQUENCE AT THE TIME OF PROCESSING, NO SEQUENCE DATABASE REFERENCE WAS AVAILABLE FOR THIS SEQUENCE. THERE IS A N19R MUTATION COMPARED TO THE WILD TYPE SEQUENCE. RCSB Y RCSB 2003-04-10 REL determined using standard 2D homonuclear techniques structures with the lowest energy and the least restraint violations 100 10 homonuclear 2D DQF-COSY, TOCSY, NOESY 40mM Na acetate buffer 4.3 ambient 298 K molecular dynamics 1 lowest energy 2mM ETD151, 40mM Na acetate buffer 90% H2O/10% D2O collection VNMR Delaglio processing NMRPipe Johnson data analysis NMRView 5.0.3 structure solution ARIA 1.1 Brunger structure solution CNX 2000.1 Brunger refinement CNX 2000.1 600 Varian INOVA ASP 1 n 1 ASP 1 A LYS 2 n 2 LYS 2 A LEU 3 n 3 LEU 3 A ILE 4 n 4 ILE 4 A GLY 5 n 5 GLY 5 A SER 6 n 6 SER 6 A CYS 7 n 7 CYS 7 A VAL 8 n 8 VAL 8 A TRP 9 n 9 TRP 9 A GLY 10 n 10 GLY 10 A ALA 11 n 11 ALA 11 A VAL 12 n 12 VAL 12 A ASN 13 n 13 ASN 13 A TYR 14 n 14 TYR 14 A THR 15 n 15 THR 15 A SER 16 n 16 SER 16 A ASN 17 n 17 ASN 17 A CYS 18 n 18 CYS 18 A ARG 19 n 19 ARG 19 A ALA 20 n 20 ALA 20 A GLU 21 n 21 GLU 21 A CYS 22 n 22 CYS 22 A LYS 23 n 23 LYS 23 A ARG 24 n 24 ARG 24 A ARG 25 n 25 ARG 25 A GLY 26 n 26 GLY 26 A TYR 27 n 27 TYR 27 A LYS 28 n 28 LYS 28 A GLY 29 n 29 GLY 29 A GLY 30 n 30 GLY 30 A HIS 31 n 31 HIS 31 A CYS 32 n 32 CYS 32 A GLY 33 n 33 GLY 33 A SER 34 n 34 SER 34 A PHE 35 n 35 PHE 35 A ALA 36 n 36 ALA 36 A ASN 37 n 37 ASN 37 A VAL 38 n 38 VAL 38 A ASN 39 n 39 ASN 39 A CYS 40 n 40 CYS 40 A TRP 41 n 41 TRP 41 A CYS 42 n 42 CYS 42 A GLU 43 n 43 GLU 43 A THR 44 n 44 THR 44 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LYS 2 A N LYS 2 A O CYS 42 A O CYS 42 A O TRP 41 A O TRP 41 A N HIS 31 A N HIS 31 1 A A H1 O ASP THR 1 44 1.59 5 A A O HG GLY SER 33 34 1.59 5 A A H2 OXT ASP THR 1 44 1.60 1 A CYS 7 -92.45 42.86 1 A VAL 12 -77.79 33.19 1 A ASN 13 -162.66 41.26 1 A SER 34 69.96 -141.01 2 A CYS 7 -84.08 43.64 2 A VAL 12 -77.75 37.51 2 A ASN 13 -172.61 44.31 2 A SER 34 59.58 -141.29 3 A CYS 7 -88.02 39.97 3 A VAL 12 -75.57 41.59 3 A ASN 13 -163.34 35.78 3 A CYS 18 -28.63 -61.49 3 A SER 34 70.45 -141.74 3 A ALA 36 68.19 -69.30 3 A ASN 37 176.79 112.55 3 A VAL 38 -164.05 -57.25 4 A VAL 12 -78.47 36.56 4 A ASN 13 -163.26 34.57 4 A ASN 17 -94.58 59.42 4 A SER 34 66.17 -149.60 5 A VAL 12 -80.20 35.62 5 A ASN 13 -153.33 26.24 5 A SER 34 56.52 -139.47 5 A ALA 36 47.35 27.74 6 A CYS 7 -84.25 44.33 6 A VAL 12 -75.06 31.81 6 A ASN 13 -165.52 42.97 6 A SER 34 64.87 -143.81 6 A ALA 36 55.20 17.44 7 A CYS 7 -85.43 34.32 7 A VAL 12 -80.03 43.43 7 A ASN 13 -178.61 44.89 7 A SER 34 61.77 -138.13 7 A ALA 36 48.81 26.81 8 A SER 34 66.51 -153.40 9 A VAL 12 56.16 17.95 9 A ASN 13 -176.45 49.64 9 A CYS 32 -85.51 43.78 9 A ASN 37 50.33 95.01 9 A VAL 38 -142.14 -45.22 10 A CYS 7 -84.32 30.51 10 A SER 34 67.32 -143.12 NMR structure of ETD151, mutant of the antifungal defensin ARD1 from Archaeoprepona demophon 1 N N A ASN 17 A ASN 17 HELX_P A ARG 25 A ARG 25 1 1 9 disulf 2.027 A CYS 7 A SG CYS 7 1_555 A CYS 32 A SG CYS 32 1_555 disulf 2.026 A CYS 18 A SG CYS 18 1_555 A CYS 40 A SG CYS 40 1_555 disulf 2.022 A CYS 22 A SG CYS 22 1_555 A CYS 42 A SG CYS 42 1_555 ANTIFUNGAL PROTEIN ALPHA-BETA PROTEIN, CSAB MOTIF (CYSTEINE STABILIZED ALPHA-HELIX BETA-SHEET MOTIF), ANTIFUNGAL PROTEIN P84156_9NEOP UNP 1 1 P84156 1 44 1P00 1 44 P84156 A 1 1 44 3 anti-parallel anti-parallel A LYS 2 A LYS 2 A SER 6 A SER 6 A ASN 39 A ASN 39 A GLU 43 A GLU 43 A GLY 29 A GLY 29 A GLY 33 A GLY 33 1 P 1